Findings of Research Misconduct, 28493 [E7-9735]

Download as PDF Federal Register / Vol. 72, No. 97 / Monday, May 21, 2007 / Notices pwalker on PROD1PC71 with NOTICES These estimates include the start-up burden and attendant costs, such as determining compliance obligations. However, non-GLBA entities will give notice only once during the clearance period ahead. Thus, averaged over that three-year period, the estimated annual burden for non-GLBA entities is 1,089,000 hours and $30,749,000 in labor costs, rounded.7 Entities that are subject to the Commission’s GLBA privacy notice regulation already provide privacy notices to their customers.8 Because the FACT Act and the proposed Rule contemplate that the new affiliate marketing notice can be included in the GLBA notices, the burden on GLBA regulated entities would be greatly reduced. Accordingly, the GLBA entities would incur 6 hours of burden during the first year of the clearance period, comprised of a projected 5 hours of managerial time and 1 hour of technical time to execute the notice, given that the proposed Rule provides a model.9 Staff also estimates that 3,350 GLBA entities under the FTC’s jurisdiction would be affected, so that the total burden for GLBA entities during the first year of the clearance period would approximate 20,000 hours and $716,000 in associated labor costs.10 Allowing for increased familiarity with procedure, the paperwork burden in ensuing years would decline, with GLBA entities each incurring an estimated 4 hours of annual burden (3 hours of managerial time and 1 hour of technical time) during the remaining two years of the clearance, amounting to 13,400 hours and $472,000 in labor costs in each of the ensuing two years. Thus, averaged over the three-year clearance period, the estimated annual burden for GLBA entities is 15,600 hours and $553,000 in labor costs. Cumulatively for both GLBA and nonGLBA entities, the average annual burden over the prospective three-year clearance period, rounded, is approximately 1,105,000 burden hours hours of clerical labor at $14.44 per hour—a combined $371.27—multiplied by 1.06426 (a combined $395.13)—for the estimated 233,400+ non-GLBA business families subject to the proposed Rule. 7 3,268,000 hours ÷ 3 = 1,089,000; $92,247,000 ÷ 3 = $30,749,000. 8 Financial institutions must provide a privacy notice at the time the customer relationship is established and then annually so long as the relationship continues. Staff’s estimates assume that the affiliate marketing opt-out will be incorporated in the institution’s initial and annual notices. 9 As stated above, no clerical time is included in the estimate because the notice likely would be combined with existing GLBA notices. 10 3,350 GLBA entities × [($34.20 × 5 hours) + ($29.80 × 1 hour)] × 1.06426 wage multiplier (see note 6). VerDate Aug<31>2005 15:57 May 18, 2007 Jkt 211001 and $31,302,000 in labor costs, rounded. GLBA entities are already providing notices to their customers so there are no new capital or non-labor costs, as this notice may be consolidated into their current notices. For non-GLBA entities, the rule provides for simple and concise model forms that institutions may use to comply. Thus, any capital or non-labor costs associated with compliance for these entities are negligible. William Blumenthal, General Counsel. [FR Doc. E7–9711 Filed 5–18–07; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case: Kartik Prabhakaran, University of Pittsburgh: Based on the report of an inquiry conducted by the University of Pittsburgh (UP), extensive oral and written admissions by the Respondent, and additional analysis conducted by the Office of Research Integrity (ORI) during its oversight review, the U.S. Public Health Service (PHS) found that Mr. Kartik Prabhakaran, former graduate student in the joint M.D./Ph.D. program at UP, engaged in research misconduct while supported by National Institutes of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), grant F30 NS50905–01 and National Eye Institute (NEI), NIH, grants 5 R01 EY005945, 5 P30 EY008098, and 5 R01 EY015291. Specifically, Mr. Prabhakaran falsified and fabricated data that was included in a PowerPoint presentation and in a paper published in Immunity (Immunity 23:515–525, November 2005). Mr. Prabhakaran’s research misconduct occurred while he was a student in the M.D./Ph.D. program for UP’s School of Medicine. He is no longer in UP’s Ph.D. program but is still enrolled in its M.D. program in the School of Medicine. The Immunity publication has been retracted (Immunity 24:657, May 2006). Mr. Prabhakaran has entered into a Voluntary Exclusion Agreement in which he has voluntarily agreed, for a PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 28493 period of four (4) years, beginning on March 15, 2007: (1) To exclude himself from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) That any institution that submits an application for PHS support for a research project on which Mr. Prabhakaran’s participation is proposed, that uses him in any capacity on PHS supported research, or that submits a report of PHS-funded research in which he is involved must concurrently submit a plan for supervision of his duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of his research contribution. Mr. Prabhakaran agreed to ensure that a copy of the supervisory plan also is submitted to ORI by the institution. Mr. Prabhakaran agreed that he will not participate in any PHS-supported research until such a supervision plan is submitted to ORI. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E7–9735 Filed 5–18–07; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Comment Request Proposed Projects Title: Case Plan Requirement, Section 442, 471(a)(16), 475(1) and 475(5)(A) of the Social Security Act. OMB No.: 0980–0140. Description: The Administration for Children and Families (ACF) is requesting authority to renew an existing information collection that is expiring October 31, 2007. The collection of information for the case plan requirement is authorized by titles IV–B, Section 422 (42 U.S.C. 422), and IV–E, Sections 471 and 475 (42 U.S.C. 471 and 475) of the Social Security Act (the Act). States must develop State plans for both Titles IV–B and IV–E that are approved by the Secretary, U.S. Department of Health and Human Services. Both plans require that States maintain a case review system that periodically reviews case plans E:\FR\FM\21MYN1.SGM 21MYN1

Agencies

[Federal Register Volume 72, Number 97 (Monday, May 21, 2007)]
[Notices]
[Page 28493]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9735]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) and the Assistant Secretary for Health have taken final action in 
the following case:
    Kartik Prabhakaran, University of Pittsburgh: Based on the report 
of an inquiry conducted by the University of Pittsburgh (UP), extensive 
oral and written admissions by the Respondent, and additional analysis 
conducted by the Office of Research Integrity (ORI) during its 
oversight review, the U.S. Public Health Service (PHS) found that Mr. 
Kartik Prabhakaran, former graduate student in the joint M.D./Ph.D. 
program at UP, engaged in research misconduct while supported by 
National Institutes of Neurological Disorders and Stroke (NINDS), 
National Institutes of Health (NIH), grant F30 NS50905-01 and National 
Eye Institute (NEI), NIH, grants 5 R01 EY005945, 5 P30 EY008098, and 5 
R01 EY015291.
    Specifically, Mr. Prabhakaran falsified and fabricated data that 
was included in a PowerPoint presentation and in a paper published in 
Immunity (Immunity 23:515-525, November 2005). Mr. Prabhakaran's 
research misconduct occurred while he was a student in the M.D./Ph.D. 
program for UP's School of Medicine. He is no longer in UP's Ph.D. 
program but is still enrolled in its M.D. program in the School of 
Medicine. The Immunity publication has been retracted (Immunity 24:657, 
May 2006).
    Mr. Prabhakaran has entered into a Voluntary Exclusion Agreement in 
which he has voluntarily agreed, for a period of four (4) years, 
beginning on March 15, 2007:
    (1) To exclude himself from serving in any advisory capacity to 
PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant; and
    (2) That any institution that submits an application for PHS 
support for a research project on which Mr. Prabhakaran's participation 
is proposed, that uses him in any capacity on PHS supported research, 
or that submits a report of PHS-funded research in which he is involved 
must concurrently submit a plan for supervision of his duties to the 
funding agency for approval. The supervisory plan must be designed to 
ensure the scientific integrity of his research contribution. Mr. 
Prabhakaran agreed to ensure that a copy of the supervisory plan also 
is submitted to ORI by the institution. Mr. Prabhakaran agreed that he 
will not participate in any PHS-supported research until such a 
supervision plan is submitted to ORI.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E7-9735 Filed 5-18-07; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.